Calista Therapeutics

Developer of CAL inhibitor for the treatment of cystic fibrosis

placeLincoln, Rhode Island, United States calendar_todayFounded 2012 groups7 employees language calistatherapeutics.com

Innovation

5 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 11 times.

YearFilings
20141
20161
20172
20211
20241

Investor mix

3 investors on record.

Investor typeCountShare
Accelerator & incubator133%
Other / undisclosed267%
Coming soon